// App-Quantinova.ai

PB1465 : Selatogrel, a Potent P2Y12 Receptor Antagonist, Dissolves Pre-Formed Platelet-thrombi in vivo

Researchers

Presenter

  • L. Crescence

Principal Investigators

  • M. Kramberg

  • M. Baumann

  • M. Rey

  • L. Panicot-Dubois

  • C. Dubois

  • M.A. Riederer

Medical Centers

  • Aix Marseille Univ, INSERM 1263, INRA 1260, Center for CardioVascular and Nutrition Research ‐ C2VN, Marseille, France

  • Idorsia Pharmaceuticals Ltd., DD Pharmacology, Allschwil, Switzerland

  • Idorsia Pharmaceuticals Ltd., Drug Discovery Biology, Allschwil, Switzerland

Locations

  • France

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved